Tuberculosis
Recurrent tuberculosis in US/Canada mostly due to relapse with same strain
Published in Medical Letter on the CDC and FDA, March 20th, 2005
"Recurrence of active tuberculosis after treatment can be due to relapse of infection with the same strain or reinfection with a new strain of Mycobacterium tuberculosis. The proportion of recurrent tuberculosis cases caused by reinfection has varied widely in previous studies.
"We evaluated cases of recurrent tuberculosis in two prospective clinical trials: a randomized study of two regimens for the last 4 months of treatment (n=1,075) and a study of a twice-weekly rifabutin-containing regimen for human...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Childhood Obesity
Parental feeding restriction increases child eating and weight status - Drug Safety
Standard deviation in estimating doses with continuous data clarified - Enzymology
Enzymes found in Mycobacterium vanhaalenii PYR-1 - Muscle Regeneration
Chemokine receptor CCR2 involved in skeletal muscle regeneration - Occupational Health
Effect of viewing angle on luminance and contrast for displays compared - Abdominal Aortic Aneurysms
Company applauds the U.S. Preventive Services for recommending AAA screening - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
